AXSM: Multiplikator Forward P/S Axsome Corp
Axsome Therapeutics (AXSM) is implementing advanced chemical methods to combat migraine and depression. The forward P/S trend visualizes market expectations, where 8.80 reflects the metric's baseline. Debt optimization is based on robust scientific potential in Alzheimer's therapy and rapid sales scaling, which effectively increases the net margin through operating leverage.
Rincian metrik lan analitis perusahaan Axsome Corp (AXSM)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Axsome Therapeutics|AXSM - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Axsome Therapeutics|AXSM - Gunggung tanggungan utang perusahaan|Utang-utang marang kapitalisasi buku Axsome Corp|AXSM - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Axsome Therapeutics|Indikator likuiditas cepet axsome.com
- rincian asil keuangan lan kelipatan valuasi:
AXSM - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Axsome Therapeutics|AXSM - Periode bali modal bisnis|Pangali Forward P/E Axsome Therapeutics Inc|AXSM - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Axsome Corp|AXSM - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Axsome Therapeutics|AXSM - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan axsome.com|AXSM - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Axsome Therapeutics
- rincian pendapatan lan dodolan:
Pambiji fundamental:Axsome Therapeutics, Inc. AXSM
The active expansion of Axsome Therapeutics (AXSM) drug distribution across neurological clinics directly impacts the trajectory of the company's forward P/S chart. This indicator compares current market capitalization with projected annual revenue, allowing investors to assess the level of market optimism priced in and determine the risk of the asset being overbought relative to expected sales growth rates.
Analisis pesaing
Biogen - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake NBIX (Neurocrine)|Regencell - Multiplikator Forward P/S|Rega forward marang dodolan ACAD (ACADIA Corp)|XENE: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep vikingtherapeutics.com (VKTX)|Rasio rega marang prakiraan pendapatan Supernus|CPRX: Rega forward marang dodolan|Multiplikator Forward P/S DNLI|Multiplikator Forward P/S Harmony Corp (HRMY)|Rasio rega marang prakiraan pendapatan Biohaven Ltd. BHVN|AMLX (amylyx.com) - Rega mangsa ngarep marang pendapatan|Trevi Therapeutics, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Praxis Precision Medicines Inc|AVXL (Anavex Corp) - Multiplikator forward rega marang pendapatan|CeriBell EEG (CBLL) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan PRTA|ALEC (Alector Therapeutics) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S ANNX|Rasio kapitalisasi marang dodolan sing dikarepake omeros.com|Multiplikator Forward P/S NGNE (Neurogene Corp)|ACIU - Multiplikator forward rega marang pendapatan|VYGR - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake neumoratx.com NMRA|SCLX: Multiplikator Forward P/S|Tevogen Bio Holdings Inc. (TVGN) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan ACOG|Kapitalisasi marang prakiraan pendapatan CGTX (Cognition Therapeutics Inc.)|Rasio rega marang prakiraan pendapatan Inhibikase Therapeutics (IKT)|Rasio kapitalisasi marang dodolan sing dikarepake cassavasciences.com|Rasio rega marang prakiraan pendapatan Assertio ASRT|COYA - Multiplikator forward rega marang pendapatan|VTGN - Rasio rega marang prakiraan pendapatan|OVID (Ovid Therapeutics Inc.) - Kapitalisasi marang prakiraan pendapatan|ABOS: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep cervomed.com (CRVO)|Multiplikator forward rega marang pendapatan ATHE|Multiplikator Forward P/S Clene Nanomedicine|Rasio rega marang prakiraan pendapatan PepGen Inc. (PEPG)|JUNS (Jupiter Neurosciences, Inc.) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Relmada Therapeutics RLMD|annovisbio.com (ANVS) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Grace Tx - Multiplikator Forward P/S|AIFF - Multiplikator Forward P/S|KLTO (anewmeds.com) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan NRSN|Rasio rega marang prakiraan pendapatan Reviva Pharmaceuticals|MetaVia, Inc. (MTVA) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan NeurAxis (NRXS)|HSDT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Passage Bio PASG|NEUP - Multiplikator forward rega marang pendapatan|Minerva Neurosciences - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep athira.com|ADXN (Addex Therapeutics Ltd) - Multiplikator forward rega marang pendapatan|Alzamend Neuro - Rega forward marang dodolan|Multiplikator forward rega marang pendapatan CYCN|PTIX (Protagenic) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S KTTA|CRGT (cortigent.com) - Rega forward marang dodolan|Multiplikator Forward P/S ATXI (Avenue Therapeutics, Inc.)|Brainstorm Cell Therapeutics Inc. (BCLI) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|CARA - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan CHRO (Chromocell)|ELYM: Multiplikator Forward P/S|Intra-Cellular Therapies, Inc. (ITCI) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Longboard Pharmaceuticals, Inc.|Marinus Pharmaceuticals Inc - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S NKGN|NRBO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Sage Therapeutics, Inc. - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S synaptogen.com SNPX|TRVN: Multiplikator forward rega marang pendapatan|Vigil Neuroscience - Rasio rega marang pendapatan sing dikarepake|WENA: Multiplikator Forward P/S|CERE - Rasio kapitalisasi marang dodolan sing dikarepake
